Our US Grantees

etan orgel

Etan Orgel, MD, MS

Children's Hospital Los AngelesA Diet and Activity Intervention to Improve Survival and Quality of Life in Obese Adolescents Receiving Therapy...more


Evripidis Gavathiotis, Ph.D.

Albert Einstein College of Medicine Targeting Anti-Apoptotic BHRF-1: A Novel Therapeutic Strategy for Epstein-Barr Virus Associated Lymphomas...more

Fay Young, M.D.

University of Rochester Medical Center Integrin and Chemokine-Mediated Homing During B Cell Ontogeny and Leukemogenesis...more

Gabriel Birrane, Ph.D.

Beth Israel Deaconess Medical Center Investigating the role of the ROBO1 protein in the development of blood cancers...more


Gang "Greg" Wang, PhD

University of North Carolina, Lineberger CCC Novel Approaches to Target PRC2 Enzymatic Complexes for the Treatment of Hematopoietic Malignancies...more

george georges

George Georges, M.D.

Fred Hutchinson Cancer Research Center T-Cells to Control the Graft-Versus-Host Effect of Nonmyeloablative Hematopoietic Cell Transplantation...more


Grant A. Challen, PhD

Washington University St. Louis...more

greg beatty

Gregory L. Beatty, M.D., Ph.D.

University of Pennsylvania Medical Center Targeting inflammation within the tumor microenvironment for cancer therapy...more


H. Daniel Lacorazza, Ph.D.

Baylor College of Medicine Role of proliferation in the pathogenesis of T-cell acute lymphoblastic leukemia...more

hao huang

Hao Huang, Ph.D.

The University of Chicago Study of the inhibitory role of miR-26 in the development of MLL-associated leukemia...more


Heidi D. Klepin, M.D., M.S.

Wake Forest University School of MedicineMinimizing physical function decline in older adults receiving chemotherapy...more

bhilda ye

Hilda B. Ye, Ph.D.

Albert Einstein College of Medicine of Yeshiva University The Role of BCL-6 Regulated Chemokine Expression in the Pathogenesis of B-Cell...more

iannis aifantis

Iannis Aifantis, Ph.D., B.S.

NYU Cancer Institute, New York University School of Medicine Modeling T-Cell A.L.L....more

ingrid ruf

Ingrid Karen Ruf, Ph.D.

University of California, Irvine Role of Epstein-Barr virus RNAs in the Pathogenesis of Virus-associated Lymphoid Tumors...more

Iris Bell, M.D., Ph.D.

University of Arizona Evaluating the Effectiveness of an Integrative Approach to the Treatment of Lymphoma and Leukemia Utilizing a Comprehensive...more

Issa Khouri, M.D.

The University of Texas M. D. Anderson Cancer Center Nonablative Allogenic Blood Stem Cell Transplantation for Patients with Indolent Lymphoid...more

james mulloy

James C. Mulloy, Ph.D.

Cincinnati Children's Hospital Microenvironment and Flt3 Signaling in MLL Leukemia...more

james rubenstein

James L. Rubenstein, M.D., Ph.D.

University of California, San Francisco Molecular Therapy of CNS Lymphoma...more

jason townson

Jason Townson, Ph.D.

University of New Mexico Cancer Research & Treatment CenterIn Vivo Models for Design and Optimization of Targeted Nanocarriers (Protocells) for...more

jeffrey rathmell

Jeffrey C. Rathmell, Ph.D.

Duke University Medical Center Bcl-2 Family Proteins as Metabolic Targets in Leukemia...more